Patents by Inventor Emily Germain-Lee

Emily Germain-Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTICS TARGETING TRANSFORMING GROWTH FACTOR BETA FAMILY SIGNALING
    Publication number: 20230414711
    Abstract: Provided herein are methods of inhibiting type 1 receptor and/or type 2 receptor signaling in subjects, optionally subjects with diseases associated with myostatin, type 1 receptor, and/or type 2 receptor signaling, or muscle loss and/or bone deterioration. Also provided are compositions for inhibition of type 1 receptor and/or type 2 receptor signaling.
    Type: Application
    Filed: November 12, 2021
    Publication date: December 28, 2023
    Applicants: The Jackson Laboratory, University of Connecticut
    Inventors: Se-Jin Lee, Emily Germain-Lee